| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate |
2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cab4f8fd9db57efb0a62ea54a7b19e10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_836d4824395ffdb94792fd517c42bbda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baf7ab9df27615f17da7fe9920b91db3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d191aedb6b1ea6a24d07354c1bb2d9 |
| publicationDate |
2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020232214-A1 |
| titleOfInvention |
Treating acute myeloid leukemia (aml) with mivebresib, a bromodomain inhibitor |
| abstract |
The present disclosure relates to methods of treating acute myeloid leukemia (AML) in a human subject in need thereof by administering an effective amount of mivebresib, optionally in combination with an effective amount of venetoclax, to the subject having AML. |
| priorityDate |
2019-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |